Affiliation:
1. University of Tsukuba
2. Ehime University
3. Juntendo University,
4. Osaka University Graduate School of Medicine
5. Osaka Center for Cancer and Cardiovascular Disease Prevention
6. Dokkyo Medical University
7. Faculty of Medicine, University of Tsukuba
Abstract
Abstract
Background/Objectives: Low intake of B-vitamins may increase dementia; However, epidemiological evidence, particularly for riboflavin (vitamin B₂), remains sparse. The aim of this study was to examine the association between dietary intakes of B-vitamins (riboflavin, vitamin B6, vitamin B12, and folate) and the incidence of disabling dementia necessitating care under the Japan’s national insurance over a 15-year observation period.
Methods: As part of the Circulatory Risk in Communities Study, a prospective study involving a community-based cohort of 4,171 Japanese individuals aged 40 to 69 years was conducted. Dietary intakes of B-vitamins were estimated through a single 24-hour dietary recall method. Hazard ratios and 95% confidence intervals of disabling dementia were estimated using area-stratified Cox proportional hazard models.
Results: Over a median follow-up of 15.4 years, 887 cases of disabling dementia were identified. Riboflavin intake was inversely associated with risk of disabling dementia among men and women; comparing the highest and lowest quartiles, multivariable hazard ratios and 95% CIs were 0.55 (95% CI 0.39–0.78; P for trend < 0.001) in men and 0.51 (0.39–0.68; P for trend < 0.001) in women. A similar inverse association was observed for vitamin B12 intake among men, and folate intake among women, with multivariable hazard ratios and 95% CIs of 0.69 (0.49–0.98; P for trend = 0.04) and 0.66 (0.49–0.88; P for trend = 0.0008), respectively.
Conclusions: Our findings suggest that dietary intake of B-vitamins, especially riboflavin, is associated with a reduced risk of disabling dementia in Japanese individuals.
Publisher
Research Square Platform LLC
Reference33 articles.
1. Vitamin B12, folic acid, and the nervous system;Reynolds E;Lancet Neurol.,2006
2. B Vitamins in the nervous system: Current knowledge of the biochemical modes of action and synergies of thiamine, pyridoxine, and cobalamin;Calderon-Ospina CA;CNS Neurosci. Ther.,2020
3. Smith AD, Refsum H. Homocysteine, B Vitamins, and Cognitive Impairment. Annu. Rev. Nutr. 2016; 36: 211–239. e-pub ahead of print 2016/07/20; doi: 10.1146/annurev-nutr-071715-050947
4. Riboflavin (vitamin B-2) and health;Powers HJ;Am. J. Clin. Nutr.,2003
5. Effect of riboflavin status on the homocysteine-lowering effect of folate in relation to the MTHFR (C677T) genotype;Moat SJ;Clin. Chem.,2003